Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Botulinum Toxin A as Treatment for Chronic Postsurgical Pain Following Lung Cancer Surgery: a Randomized Controlled Pilot Trial

NCT04585620 is registered in ClinicalTrials.gov with Allan Vestergaard Danielsen, MD as lead sponsor.

NCT NCT04585620
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04585620 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Botulinum Toxin A as Treatment for Chronic Postsurgical Pain Following Lung Cancer Surgery: a Randomized Controlled Pilot Trial
Lead sponsor
Allan Vestergaard Danielsen, MD
Phase
Phase 1/2
Overall status
Unknown status
Start date
September 1, 2022
Completion date
January 31, 2024
Enrollment
30 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

chronic pain, pain, neuropathic, pain, postoperative, post-thoracotomy pain syndrome